Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SHE:301096)

China flag China · Delayed Price · Currency is CNY
58.45
+3.87 (7.09%)
At close: Jul 31, 2025, 2:57 PM CST
7.09%
Market Cap6.47B
Revenue (ttm)714.95M
Net Income (ttm)-128.76M
Shares Out108.45M
EPS (ttm)-1.19
PE Ration/a
Forward PE121.80
Dividendn/a
Ex-Dividend Daten/a
Volume17,578,014
Average Volume5,820,048
Open48.35
Previous Close54.58
Day's Range48.35 - 60.00
52-Week Range30.60 - 60.00
Beta0.45
RSI83.91
Earnings DateAug 27, 2025

About Intra-Cellular Therapies

Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. operates as a pharmaceutical technology research and development and services company in China. The company primarily provides drug research and development services; and the transformation of research and development technology results for various pharmaceutical, as well as pharmaceutical research and development investment companies. Its business covers the principal links of drug discovery, pharmaceutical research, clinical trials, customized research and development and production, and registratio... [Read more]

Sector Healthcare
Founded 2011
Employees 1,834
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301096
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.